97016583 - INVICRO A KONICA MINOLTA COMPANY

Information

  • Trademark
  • 97016583
  • Serial Number
    97016583
  • Filing Date
    September 08, 2021
    3 years ago
  • Transaction Date
    January 19, 2023
    a year ago
  • Status Date
    January 19, 2023
    a year ago
  • Location Date
    January 19, 2023
    a year ago
  • First Use Anywhere Date
    March 01, 2018
    6 years ago
  • First Use In Commerce Date
    March 01, 2018
    6 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    JOHNSON, DANYTHE ELIZA
  • Attorney Docket Number
    106517999111
    Attorney Name
    Carrie L. Kiedrowski
    Law Office Assigned Location Code
    N20
  • Owners
Mark Drawing Code
3000
Mark Identification
INVICRO A KONICA MINOLTA COMPANY
Case File Statements
  • GS0411: Educational services, namely, developing, arranging and conducting educational programs, panel discussions and webinars in the fields of pharmaceuticals, biotechnology, pre-clinical and clinical trials, and medical research; educational services, namely, providing non-downloadable publications, and literature in the fields of pharmaceuticals, biotechnology, pre-clinical and clinical trials, and medical research
  • DM0000: The mark consists of an image of an overhead shot of a microscope/magnifying glass with a loupe in the circle with the word "Invicro" to the right of the image and the words "A Konica Minolta Company" directly beneath the word "Invicro".
  • GS0091: Downloadable computer software for processing, visualizing, storing and analyzing pre-clinical and clinical radiology and pathology image data in the fields of drug development and disease research; downloadable computer software for image data management purposes, namely, pre-clinical and clinical image database management and research subject records management; downloadable computer software for processing multi-modal imaging data; downloadable computer software for the processing, storage and analysis of multi-modal imaging data for quantitation and evaluation of biomarkers and drug candidates; downloadable software for the assessment of tumors for research through use of biomarkers
  • GS0441: Medical imaging services; medical imaging and radiology services related to drug development; research services in the fields of magnetic resonance and molecular imaging; medical research services, in particular services relating to the development of radiotherapeutics and drug candidates for neurodegenerative diseases and precision oncology; image analysis and radiology, namely, analysis of images from all radiological modalities, such as but not limited to CT, MRI and PET scans to provide quantitative evaluation of drug candidates medical radiology, namely, molecular imaging, imaging utilizing radiopharmaceuticals; radiomics, namely, medical radiology services; medical imaging services, namely, medical imaging and extraction of imaging biomarkers; pathology services, namely, testing for research purposes in the fields of pharmaceuticals and biotechnology; pathology services for preclinical biomarker discovery research and clinical trials
  • GS0421: Medical and scientific research, namely, conducting clinical and pre-clinical trial services for others; pharmaceutical research and development services; testing of pharmaceutical pharmacodynamics, pharmacokinetics and efficacy using a variety of imaging modalities and imaging analysis platforms; imaging services and pathology in support of pharmaceutical research and development; drug discovery services; conducting early evaluations in the field of new drugs; scientific investigations for medical research purposes; medical and scientific research laboratory services; medical and scientific research, namely, providing analysis of imaging data obtained from pre-clinical and clinical trial studies; medical and scientific research in the fields of medical radiology imaging, pathology and digital pathology; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; research and development in the fields of medical imaging, pharmaceuticals and biotechnology; design, development, maintenance and updating of computer software for image processing, storage and analysis in the fields of pharmaceuticals and biotechnology; electronic storage of medical images; processing and analysis of medical images; pathology services in support of drug development; hosting of a medical imaging analysis and visualization platform through a global computer network; hosting of a database of medical images; software as a service (SAAS) featuring computer software platforms for image processing, storage and analysis in the fields of pharmaceuticals and biotechnology; conducting clinical trials for others at all stages and in various indications, particularly in oncology, neurology and systemic diseases; imaging contract research organization services and technology solutions, namely, imaging services for medical and scientific research purposes and technology solutions, namely, reviewing of radiology images throughout the clinical trial process and blinded independent central review of radiology images in the medical research and clinical trial setting; scientific research services, namely, integration of imaging results with clinical outcome data, with application of machine learning and artificial intelligence applications; development and evaluation of imaging biomarkers for clinical trial purposes; software consulting services in the field of drug discovery; cloud computing featuring software for use in pharmaceutical drug research in the field of drug discovery; radiochemistry services; research, development and testing services relating to radiopharmaceuticals; radiolabeling scientific research, namely, labeling of both small molecules and biologics; providing non-downloadable web-based computer software for database management in the fields of medical imaging, pharmaceutical and biotechnology research
Case File Event Statements
  • 1/19/2023 - a year ago
    15 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 1/19/2023 - a year ago
    14 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 1/19/2023 - a year ago
    13 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 12/6/2022 - 2 years ago
    12 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 12/6/2022 - 2 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/6/2022 - 2 years ago
    10 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/6/2022 - 2 years ago
    9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/6/2022 - 2 years ago
    8 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/7/2022 - 2 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/7/2022 - 2 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/7/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/13/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/19/2021 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/18/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/11/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP